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Abstract
Background: Tuberculosis remains one of the most important causes of global mortality and morbidity, and the molecular
mechanisms of the pathogenesis are still incompletely understood. Only few virulence factors of the causative agent
Mycobacterium tuberculosis are known. One of them is the heparin-binding haemagglutinin (HBHA), an important adhesin
for epithelial cells and an extrapulmonary dissemination factor. HBHA mediates mycobacterial adherence to epithelial cells
via the interactions of its C-terminal, lysine rich repeat domain with sulfated glycoconjugates on the surface of epithelial
cells.
Methodology/Principal Findings: Using defined heparin sulfate (HS) analogs, we determined the minimal heparin fragment
length for HBHA binding and structural adaptations of the HBHA heparin-binding domain (HBD) upon binding to heparin.
The NMR studies show significant shifts of all residues in the HBD upon interaction with heparin, with stronger shifts in the
last repeats compared to the upstream repeats, and indicated that the HS fragments with 14 sugar units cover the entire C-
terminal lysine-rich domain of HBHA. The differential implication of the repeats is determined by the relative position of
prolines and lysines within each repeat, and may contribute to binding specificity. GAG binding induces a non-
homogeneous structural rearrangement in the HBD, with stabilization of a nascent a-helix only in the last penta-repeats.
Conclusion/Significance: Mycobacterial HBHA undergoes structural adaptation upon interaction with GAGs, which is likely
involved in binding specificities of the adhesin, and mycobacterial pathogens may use HBD polymorphisms for host or
organ specificity. Further studies will aim at decoding the complementarity between HBD repeats and HS sequence.
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Introduction
Tuberculosis is a world-wide leading cause of mortality due to an
infectious agent. Because of the complexity of the disease and the
virulence of its causative agent Mycobacterium tuberculosis, the molecular
mechanisms of pathogenesis are still incompletely understood [1].
One of the few characterized mycobacterial virulence factors is the
cell wall-associated Heparin-binding Haemagglutinin (HBHA) (for
review, see [2]). It was initially identified as one of the major adhesins
involved in binding of M. tuberculosis to the epithelial cells via
interactions with heparan sulfate (HS) Glycosaminoglycans (GAGs)
[3,4,5]. Subsequently, it was found to be a key factor in the
extrapulmonary dissemination of the bacilli [6,7,8]. In addition to
beinganimportantvirulencefactor,HBHAisalsoapotentprotective
antigen [9,10] that may be used as diagnostic tool, in particular for
the detection of latently infected subjects [11], and as a vaccine
candidate, especially to strengthen and prolong Bacille Calmette &
Gue ´rin (BCG)-induced immunity [12,13,14].
HBHA is a 198 residues protein organized in four domains : a
hydrophobic domain (residues 5 to 18) [15], a coiled-coil domain
(24 to 109) [15,16,17], a linker domain (110–159) [17] and a
cationic lysine-rich domain (160 to 198) [5]. The latter domain is
essentially composed of alanine, proline and lysine residues,
organized in two types of lysine-rich repeats, R1 and R2. R1
(KKAAPA) is directly repeated thrice between residues 160 and
177, whereas R2 (KKAAAKK) is repeated twice between residues
178 and 194, and both R2 repeats are separated by APA. The
sequence can also be read as a repetition of three hexa-repeats
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32421(KAAPAK) and three penta-repeats (KA(A/P)AK), whereby the
two lysine residues of these latter are separated by a triple A or by
a APA tripeptide. This latter reading will be adopted in this
manuscript. These repeats constitute the heparin-binding domain
(HBD) of HBHA and are responsible for binding of HBHA to
Heparan Sulfate (HS) GAGs [5].
Complex HS-GAGs are found on cell surfaces and in the
extracellular matrix of most animal tissues. Many secreted proteins
bind to these polysaccharides, usually to the heparin-like regions of
HS. The essential role of protein-GAG interactions in the
regulation of various physiological processes has been recognized
since several decades, but only recently the molecular bases
underlying these interactions have emerged [18]. The cell surface
GAGs are actively involved in barrier regulation; interactions with
cationic peptides induce signaling events that lead to increased
endothelial permeability and cytoskeletal reorganization [19].
Previous work has shown that the repeats mediate the binding of
HBHA to respiratory epithelial cells [5], and that treatment of
these same epithelial cells with heparinase III leads to a strong
reduction in HBHA binding. Furthermore, anti-HBHA monoclo-
nal antibodies were shown to effectively disrupt the interaction
between HBHA and epithelial cells, thereby reducing the
extrapulmonary dissemination of the bacteria [20]. HBHA-coated
beads are able to transcytose epithelial cell layers and induce
cytoskeletal rearrangements [8]. The interactions of HBDs with
HS are dominated by electrostatic forces between basic amino acid
residues, such as lysines, and the negatively charged sulfates of HS.
Therefore, heparin is commonly used as a model compound to
study these interactions.
Heparin is a repeating linear copolymer of a-L-uronic acid or
b-D-glucuronic acid (1R4)-linked to a glucosamine residue.
Whereas the most common structure in heparin is the trisulfated
disaccharide, a number of structural variants exist, rendering it
micro-heterogeneous. Heparin is polydisperse with an average
chain length of 13 kDa in commercial heparin, and ranges from 5
to 40 kDa. Initial structure-function studies of HBHA have used
micro-heterogeneous and polydispersed commercial heparin. To
gain further insights into the HBHA-HS interactions, we use here
size-defined heparin-derived oligosaccharides to determinate the
minimal length required for binding to HBHA. With these defined
oligosaccharides, we then set out to characterize the resulting
complex at the molecular level.
Results
Defining the minimal binding partners
To determine the minimal length of the heparin fragment
required for HBHA binding, heparin-derived oligosaccharides
ranging in size from dp4 to dp14 were used in a mobility shift
assay. The oligosaccharides (5 nmol per sample) were incubated
with 0.2 nmol of HBHA and subjected to non-denaturant
electrophoresis (Figure 1A and B). In these conditions, HBHA is
positively charged and cannot shift to the anode. However, charge
compensation by complex formation with negatively charged
heparin fragments allows the migration of the complex, and can
thereby be visualized as a shifted band at the top of the gel. The
unbound oligosaccharides in excess are visible in the middle region
of the gel. Tetra- and hexa-saccharides were not significantly
shifted in the presence of HBHA, indicating that they were
inefficient in forming complexes with HBHA. In contrast,
significant amounts of octasaccharides and larger oligosaccharides
were shifted in the presence of HBHA. Cyclophilin B (CycB) and
dp10 were used as positive controls for interaction, as the
heparin:CycB interaction was previously described and HBHA
and Cyclophilin B have similar values for pI and molecular weight
[21]. These results indicate that the minimal length of heparin
capable of interacting with HBHA is between 8 and 10 sugar units.
For subsequent studies, we used the dp14 fragment.
The chimeric protein consisting of the maltose-binding protein
(MBP) and the HBD domain of HBHA grafted onto its C-
terminus (MalE-Ct) showed the same affinity as HBHA for
heparin as measured by surface plasmon resonance, and hence
allowed to ascertain that the tail region of HBHA is solely
responsible for HS binding [5]. We here find that it exhibits the
same profile on the gel mobility shift assays in the presence of our
heparin derivatives (Figure 1, C and D). The C-terminal domain
hence recognizes the same heparin length distribution when
integrated into full-length HBHA or when grafted onto the C-
terminus of MBP.
Structural independence of the HBD
To further ascertain that the HBD is independent of the rest of
the protein, we recorded
1H,
15N HSQC spectra of
15N-labeled
samples of both proteins (Figure 2). Although more resonances
were visible in the spectrum of HBHA, possibly reflecting the
presence of the flexible linker region that was shown to stabilize
the coiled coil region of HBHA [17], the only resonances of MalE-
Ct that were visible perfectly match a subset of the HBHA
resonances (Figure 2). Finally, we recorded under similar
conditions the
1H,
15N HSQC spectrum at natural abundance
of a synthetic peptide corresponding to the HBD. We recovered
the peaks common to HBHA and MalE-Ct for most residues of
the synthetic peptide. Only for the extreme N- and C-terminal
positions we observed slightly different chemical shift values, which
can be related to the lack of any N-terminal extensions (the rest of
the HBHA protein or Mal) ) and C-terminal amidation of the
synthetic peptide (Figure 2).
Molecular characterization of HS binding by NMR
assignment of MalE-Ct bound to dp14
Resolving individual resonances of the HBD was attempted by
triple resonance NMR spectroscopy on a
13C,
15N-labelled MalE-
Ct sample. Despite the high magnetic field corresponding to a
proton frequency of 900 MHz, the majority of resonances could
not be resolved or assigned unambiguously in the highly repetitive
sequence. Only some residues of the C-terminal part and of the
non-degenerate 5
th repeat sequence 183KKAPA187 could be
assigned in a sequence-specific manner (Figure 2). For the other
resonances, the nature of the corresponding amino acid (and its (i-
1) neighbour) could be deduced from the carbon Ca and Cb
chemical shift values, but a sequence-specific assignment was not
possible.
Next, we recorded the HSQC spectrum of MalE-Ct in the
presence of a fivefold excess of dp14, and observed a general
upfield shift of most resonances, with shifts attaining 0.15 ppm in
the proton direction (Figure 3A). In addition to the shifts, the
number of peaks in the spectrum greatly increased, suggesting that
the interaction with dp14 reduces to some extent the degeneracy
of the different repeats. An example is given by the intense
resonance at 8.56/126.73 ppm, that we assigned to the (K)A(A)
motif in the spectrum of MalE-Ct without dp14 (Figure 3A), and
that corresponds to the amide correlation of 5 Ala residues in the
HBD. Upon interaction with dp14, this resonance splits up into
five individual resonances that could be divided in two groups.
The first group contains three distinct peaks, that we assigned to
the (K)A(AP) resonance in the first three repeats (A3, A9 & A15,
see below), whereas the second group contains the (K)A(AA) motif
of the fourth and sixth repeat (A21+A31 see below). Remarkably,
GAGs Binding Mechanism of HBHA
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of the resonances in the first group.
The Ca/Cb carbon chemical shift values unambiguously
indicate the nature of the amino acid and its (i-1) upstream
neighbour, but do not allow us to connect individual resonances,
as the degeneracy at the level of the carbon chemical shift values
remains even in the presence of a saturating amount of dp14. As
an example, the Ca/Cb carbons of the central Ala residue of the
previously mentioned (K)A(A) motif. adopt values of 52.2/
19.2 ppm in the first three repeats, close to the values of 52.6/
19.02 ppm predicted on the basis of a set of intrinsically
unstructured proteins (Table S1: predicted chemical shifts). In
repeats 4 and 6, where an Ala rather than a Pro residue follows the
KAA tripeptide, the values are 52.6/19.04 ppm, which is even
closer to these predicted random coil values. The carbonyl CO
resonances show the same degeneracy. Therefore, only the
reasonable
15N dispersion could be exploited in the third indirect
dimension of the HNN experiments to link peaks together. As a
result, peaks could be assembled corresponding to every single
repeat (Figure S1). Not unexpectedly, resonances in the first three
hexa-repeats (defined here as KAAPAK) can be grouped by their
weak, intermediate or strong shift.
In order to unambiguously assign the resonances to the
individual repeats, we synthesized a peptide with a single
15N-
Ala in every repeat. As expected, we obtained a spectrum with
only 6 resonances that coincide perfectly with the resonances of
the corresponding Ala residues in U-
15N labelled MalE-Ct, (Figure
S2). Upon addition of a tenfold excess of dp14 to the peptide,
while maintaining the same absolute concentration of 60 mM
peptide, cross peaks shifted in a manner similar to those observed
with the recombinant proteins. Superposition of the peptide
spectra allowed us to establish that shifts of the resonances in the
first group corresponding to the first three repeats obey the order
of occurrence, with the smaller shifts observed for residues in the
first group, intermediate shifts in the second repeat and the most
pronounced shifts in the third repeat. A full sequence-specific
assignment of this highly degenerate C-terminal peptide was thus
possible in the presence of dp14 (Figure 3), and allowed us to
conform that shifts in the 4
th and 6
th KAAAK penta-repeats are
more pronounced (Figure 3B).
GAG binding induces structural changes
In order to evaluate potential structural changes upon heparin
binding, we looked for Ca and Cb chemical shift differences upon
dp14 binding. The degenerate (K)A(A) amide cross peak equally
shows that in isolated HBHA, the Ca and Cb of both the first K
and second A residue are identical for all repeats, R5 excepted
(Fig. 4, left panel, black and red; and corresponding zooms). After
Figure 1. Analysis of the oligosaccharide minimal unit length required for HBHA binding. Oligosaccharides from dp4 to dp14 (5 nmol of
each dp oligosaccharide per lane) were incubated with 0.2 nmol of HBHA (A & B) or MalE-Ct (C & D) and subjected to mobility shift assays. The
migration of the oligosaccharides was visualized by coloration with azur blue (A & C) and that of the proteins by Coomassie blue staining (B & D).
Cyclophilin B (CycB) and free HBHA or MalE-Ct were used in the positive and negative control lanes, respectively.
doi:10.1371/journal.pone.0032421.g001
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resonances of R4 and R6 (Figure 3B), we find that the Ca and
Cb resonances of the K and A residues in the latter R4 and R6
repeats shift towards more a-helical values (Figure 4, top, light
green). The Ca shift of 0.4 ppm would not classify those residues
as a stable helix according to the Chemical Shift Index [22], but
does indicate a nascent a-helix [23,24,25]. The equivalent residues
in the R1–R3 (K)A(AP) repeats show no or slightly opposite
variations (Figure 4, top, pink and dark green), showing that they
cannot evolve towards a more helical conformation upon heparin
binding. When we apply the same analysis for the unique
(K)APA(K) R5 repeat, chemical shift differences are smaller but
evolve in the same direction as the KAAAK R4–R6 pentarepeats
This unexpected result indicates that a central Pro in the repeat
still is compatible with a helix induction through heparin binding,
whereas the same Pro integrated in a hexarepeat imposes a more
extended conformation to accommodate the heparin binding.
Thermodynamic characterization of the interaction of
HBHA with dp14
The differential shifts for similar residues in different repeats
could originate from several independent binding events or from
the same binding event that is perceived in a differential manner
by the individual repeats. To distinguish between these two
possibilities, we determined the apparent dissociation constant by
recording the
1H,
15N HSQC of MalE-Ct with increasing amounts
of dp14 in a NMR titration experiment (Figure S3B). The
observed gradual peak shifts clearly indicate that we are in the fast
exchange regime on the NMR time scale, allowing to extract
dissociation constants by fitting the corresponding chemical shift
variations to the dp14 concentrations. A typical titration curve is
shown in Figure S3F, and indicates a KD value of 58.8614 mM for
dp14 (Figure S3D). When this value was extracted on different
resonances, the same range of values was found for all of them
(Figure S3D and E), suggesting that we observed the binding of a
single dp14 to the HBD of HBHA (Figure S3). We performed the
same titration experiment with the shorter dp10 and determined a
KD of 79.4623 mM (Figure S3D and F) indicating a slightly less
tight interaction than for dp14, in agreement with our earlier gel
shift results (Figure 1). Again, the values were identical irrespective
of the resonance used. However, when dp4 was added to the same
protein, hardly any shift was observed (Figure S3C), which is in
agreement with the lack of binding of dp4, as evidenced by the gel
shift assays (Figure 1).
A penta- and hepta-repeat code for different
mycobacterial species?
Chemical shift differences upon complex formation with dp14
are more pronounced for the penta-repeats 4, 5 and 6 than for the
three N-terminal hexa-repeats, and are moreover accompanied by
Ca and Cb changes that indicate a more pronounced helical
tendency upon heparin binding. The pronounced shifts observed
for residues in penta-repeat 5, characterized by a central proline
residue (KAPAK), might result from its strong contribution to the
binding, but, alternatively, it might also stem from the presence of
the two flanking KAAAK penta-repeats 4 and 6 that themselves
enhance binding. We therefore examined the distribution of
equivalent repeats in different mycobacterial species (Figure 5).
Whereas the C-terminal domains of HBHA from at least 4 species
align perfectly with that of M. tuberculosis HBHA, Mycobacterium
avium subsp. avium (Maa) has a HBHA sequence that contains
mostly penta-repeats with a central proline residue. Only the last
repeat is of the KAAAK type.
In order to investigate whether this sequence divergence
influences the heparin-binding properties, we compared the ionic
strength required to elute recombinant HBHA of M. tuberculosis
and Maa from a heparin sepharose column. Both proteins eluted at
0.59 M NaCl, suggesting that their binding to unfractionated
heparin is comparable. Next, we produced Maa HBHA in
Escherichia coli as a
15N-labelled protein, and performed compar-
Figure 2.
1H,
15N HSQC at 46C and 900 MHz spectrum of recombinant U-
15N labeled HBHA (green), U-
13C,
15N labeled MalE-Ct
(black) and the synthetic peptide at natural abundance (red). Sequence-specific assignments are indicated.
doi:10.1371/journal.pone.0032421.g002
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were observed for Maa HBHA and for HBHA from M. tuberculosis
(Figure 6). The derived dissociation constants for Maa HBHA
(KD=47mM68) closely match those determined for M.
tuberculosis HBHA (KD=5366 mM) (Figure S3D). These obser-
vations suggest that the presence of penta-repeats defines the
affinity towards HS, irrespectively of the presence of a central
proline. Interestingly, the HBHA sequence of Mycobacterium
smegmatis contains only a single C-terminal penta-repeat, with a
central proline residue (Figure 5). Previous studies have shown
that the ionic strength required to elute M. smegmatis HBHA from
heparin-sepharose is significantly lower than for the M. tuberculosis
HBHA [26], and that the M. smegmatis HBHA does not bind
epithelial cell surfaces.
Discussion
The interaction between GAGs and the HBD of HBHA is one
of the key events in the biological activities of HBHA, as it is the
basis of adherence of M. tuberculosis to epithelial cells [5] and of the
subsequent extrapulmonary dissemination of the bacilli. HBHA-
like molecules are produced by all mycobacteria investigated so far
[2], and are likely to play important roles in the virulence of
pathogenic mycobacteria, such as M. avium spp [27] and
Mycobacterium leprae [28], but their role in non-pathogenic
mycobacteria is less clear [26]. We report here the molecular
and structural characterization of this interaction. By using
heparin-derived oligosaccharides of defined lengths we defined
the minimal size of oligosaccharide for the interaction between
Figure 3. (A) HSQC spectrum of U-
13C,
15N labeled MalE-Ct at 4uC and 900 MHz (black) and of the same sample after addition of a 5.6-fold excess of
dp14 (red). Sequence-specific assignments of the HBD are indicated. (B) Plot of weighted chemical shift differences in 2D
1H/
15N HSQC spectra of
HBD-bound vs free HBD as a function of residue number. Residues with the most significant chemical shift changes upon dp14 binding are shown in
grey. Proline residues and residues that could not be assigned are marked with an asterisk.
doi:10.1371/journal.pone.0032421.g003
GAGs Binding Mechanism of HBHA
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oligosaccharides has been validated as an appropriate tools to
study the molecular interactions of HBD with HS chains [29], and
many structural and biological studies using defined oligosaccha-
rides were consistent with the in vivo biological data [30]. We
observed that the minimal binding unit for HBHA is a dp8/dp10.
This was determined by gel mobility shift assays and confirmed by
NMR titration experiments. This is in apparent contradiction with
our earlier report of a 3 kDa heparin fraction not protecting the
recombinant HBHA against prote ´olytic degradation [5]. Howev-
er, analysis of the gel filtration profile of the previously used
fractions showed that they contained a major fraction of very short
dp2/dp4 oligosaccharides, that indeed interact very poorly with
HBHA (Figure 1). The heparin fragments of this study were
purified and controlled by HPLC, are therefore more homoge-
neous in size and allow to set the lower limit for HBHA interaction
at the level of a dp8.
By using NMR titration experiments, the dp14 KD value for the
interaction with HBHA was determined to be 5366 mM. This
value is consistent with the ionic strength of 0.59 M NaCl necessary
to elute HBHA from a heparin-sepharose column [5]. KD values in
the mM ranges have been associated with elution from heparin-
sepharose at concentrations of 0.3–0.4 M NaCl [31].
The main conclusion of our NMR titration experiments is that
we can deconvolute in detail the contribution of the different
repeats within the HBD of HBHA. Because the interaction of the
HBD with a saturating amount of dp14 lifts, to some extent, the
degeneracy of the NMR spectrum, we could assign all the
individual cross peaks in the HSQC spectrum (Figure 3). As a
result of this per-residue view of the molecular interaction, we can
come to the following two conclusions. First, the KD values derived
from the shift of cross peaks for the same residue in each repeat are
similar. This argues against the existence of more than one binding
site with differential affinity. Secondly, the more pronounced
chemical shift differences residues in the R4–R6 penta-repeats
suggests that the lysines in the C-terminal penta-repeats are more
directly involved in the molecular interaction of the HBHA HBD
with dp14. Carbon chemical shift values give an explanation for
this, as they indicate an increased helical tendency only for
residues in these R4–R6 repeats. Previous studies with model
peptides composed of only Lys and Ala residues indicated that an
alternating spacing of 3 and 4 Ala residues between 2 Lys residues
was optimal for presenting the lysine side chains to the negative
sulfate clusters on the heparin surface [32], thereby strongly
stabilizing a heparin-induced a-helical structure of the model
peptide [32]. The HBHA sequence of M. tuberculosis deviates in
two aspects from this model peptide. First, instead of individual
lysine residues, as in the model peptide, the HBHA HBD contains
di-lysines sequences (Figure 5). Secondly, the residues that separate
two consecutive lysine clusters are canonical Ala triplets only in
repeats 4 and 6, whereas they contain a central proline residue in
all other repeats. However, the HS KD value of 80 mM observed
for the interaction with the Lys-Ala model peptide (35) is very
similar to that of dp14 found here for the interaction with the
HBHA HBD. In general, heparin-binding proteins feature a large
range of HS affinities, with the determining factor being the spatial
display of the positive charges. Our results indicate that the repeats
in HBHA can adapt differentially to the presence of HS to provide
charge and/or structure complementarity.
Only few examples of GAG-binding domains with prolines have
been described. Using a synthetic 7-mer random peptide library
composed of the 20 natural amino acids, Caldwell et al. [33] have
found proline-containing peptides after purification on GAG-
sepharose. It has been suggested that the reverse turn induced by
proline is important for the interaction of hepatocyte growth factor
with heparin [34]. Furthermore, in the vaccinia virus envelope
protein A27, a turn-like structure introduced by a single KKPE
segment has been shown to be responsible for its specific binding
to HS [35]. Here, we describe a novel example, in which the
insertion of a proline residue between two lysines allows to
maintain a strong affinity of the mycobacterial HBHA HBD for
GAGs. The precise reason for the proline insertion within the
lysine-rich repeats remains to be determined.
The observation that cross peaks belonging to residues of the
proline-containing hexa-repeats shift significantly less than their C-
terminal counterparts led us to consider the HBHA primary
sequences of the different mycobacterial species as a code for
heparin binding. The Maa HBHA contains only a single KAAAK
Figure 4. Strips through the HNCACB peaks of isolated MalE-Ct (black and red, for positive and negative contours), and of the
MalE-Ct with an excess of heparin (colours). The top panel shows the degenerate (K)A(A) resonance (left panel, black and red; and
corresponding zooms) in isolated HBHA, that splits in the (K)A(AP) resonances (pink and dark green) and in the (K)A(AA) resonances of R4 and R6
(light green). The bottom panel shows the strips through the isolated (K)A(PA) resonances of R5.
doi:10.1371/journal.pone.0032421.g004
Figure 5. Multiple alignment of HBHA HBDs from different Mycobacterium species. Alignments were done using the Kalign algorithms [41].
Conserved lysine residues are highlighted in grey and conserved proline residues in black.
doi:10.1371/journal.pone.0032421.g005
GAGs Binding Mechanism of HBHA
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repeats. Despite this, the affinity of this HBD for dp14 was similar
as that of the M. tuberculosis HBD, as evidenced by NMR titration
experiments. Therefore, we conclude that a proline in a penta-
repeat is more compatible with HS binding than the same proline
in a hexarepeat. Considering the variability of the cellular HS-
GAGs, it is _ENREF_29tempting to speculate that mycobacterial
pathogens use HBD variability for host or organ specificity [36].
Further investigation of this complemantrity and subsequent
specificity is currently ongoing in our laboratory.
Materials and Methods
Bacterial strains, growth conditions and DNA
manipulations
Maa ATCC 25291 was grown at 37uC in Sauton medium [37]
or Middlebrook 7H9 broth (Difco Laboratories, Detroit, MI), with
0.2% glycerol and albumin-dextrose-catalase (ADC) enrichment
medium (Becton Dickinson, Le Pont de Claix, France). Bacteria
were harvested at mid-log phase and kept frozen (280uC) in
aliquots until further use. E. coli BL21(DE3) (Novagen, Darmstadt,
DE), E. coli TOP10 (Invitrogen Carsbad, CA) and E. coli XL1-Blue
(Stratagene, Le Jolla, CA) were grown in LB medium [38]
supplemented with 30 mg/mL kanamycin as appropriate. Restric-
tion enzymes, T4 DNA ligase and other molecular biology
reagents were purchased from New England Biolabs, Roche or
Promega. PCRs were performed using a Bio-Rad thermal cycler
model iCycler, and the PCR products were sequenced by
GenomExpress (Grenoble, France).
Cloning, sequencing of the Maa HBHA-coding gene
The HBHA-coding gene (Genbank accession number:
JN129485 ) was amplified by PCR from chromosomal DNA of
strain Maa ATCC 25291 using the Pfu DNA polymerase
Figure 6. Determination of dissociation constants by NMR titration. Representative
1H,
15N HSQC NMR spectra of M. tuberculosis HBHA (A)
and Maa HBHA (B) with increasing amounts of dp14 (free HBHA (black), 0.5 dp14:HBHA (red), 1 (blue), 2 (purple), 5 (green)), whereby the peak shifts
were used for the determination of the dissociation constants. Chemical shift differences were calculated as Dd
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DdH ðÞ
2z0,2 DdN ðÞ
2
   r
with DdH
and DdN the observed chemical shift changes for
1H and
15N, respectively. For the determination of dissociation constants, Dd was plotted as a
function of the molar ratio (dp14:protein) The derived titration curves are shown in (C) for the M. tuberculosis HBHA (N) and the Maa HBHA (m).
doi:10.1371/journal.pone.0032421.g006
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following sequences: 59- TATACATATGACCATGGCGGAA-
AACCCGAACATCG -39 (Maa-hbha S) and 59- ATAT-
AAGCTTGGTACCCACGAGGTGGTTCACGCC -39 (Maa-
hbha AS), containing a NcoI and a HindIII site, respectively
(underlined). The fragment was amplified after a short denatur-
ation cycle of 3 min at 95uC by using 35 cycles as follows: 95uC for
30 s, 57uC for 30 s, and 72uC for 30 s with a final elongation cycle
at 72uC for 10 min. The PCR product was inserted into pCR2.1-
TOPO (Invitrogen) after the addition of an adenylated extension
according to the instructions of the supplier. After sequencing, the
fragment containing the HBHA-coding sequence was digested by
NcoI and HindIII and then inserted into pET-24d(+) (Novagen),
generating pET::Maahbha. This plasmid was used to transform E.
coli XL1-Blue for sequencing.
Production of recombinant HBHA derivatives
Recombinant full-length HBHA from BCG and Maa 25291 and
the maltose-binding protein (MBP) containing the C-terminal,
lysine-rich domain of HBHA (MalE-Ct) were produced in E. coli
BL21(DE3) and B834, respectively. Electrocompetent BL21(DE3)
and B834 were transformed with pET-HBHA and
pMAL+3R1+2R2 [5], respectively, and transformants were
selected on LB agar plates containing respectively 25 mg/mL
kanamycin and 50 mg/mL ampicillin. From a single colony, an
overnight culture (20 mL) was grown at 37uC in LB media
supplemented with the relevant antibiotics. These overnight
cultures were used to inoculate 2 L of the same media at a 1/
100 dilution for the production of recombinant proteins used in gel
shift assays and in 2 L of M9
15No r
15N/
13C+0.1% Isogro
15No r
15N/
13C (Sigma-Aldrich, France) for the production of recombi-
nant proteins used in NMR studies. We did note that production
in the minimal medium led to less protein degradation than in the
rich LB medium. The resulting cultures were grown to an OD600
value of 0.8 and then treated with 1 mM isopropyl-dithiogalacto-
side and grown for an additional 4 h at 37uC. Cells were harvested
by centrifugation at 5,0006g for 20 min at 4uC and stored frozen
at 220uC until further use.
Protein purification
Frozen cell pellets were resuspended in 40 mL 20 mM
phosphate-buffer containing 0.15 mM NaCl, 0.1% Triton X100,
supplemented with COMPLETE free inhibitor cocktail EDTA-
free (Roche) and DNaseI (10 mg/mL). The cells were disrupted
using a French press cell, and lysates were clarified by
centrifugation at 17,0006g for 30 min at 4uC. The bacterial cell
extracts were then loaded onto a 1 mL Heparin Hi-trap column
(GE Healthcare) equilibrated in 20 mM phosphate buffer
containing 0.15 M NaCl, washed with 20 mM phosphate buffer
containing 0.25 M NaCl and eluted with 20 mM phosphate buffer
containing 0.65 M NaCl. The HBHA- or MalE-Ct-containing
fractions were pooled and then fractionated by size exclusion
chromatography using a Superdex 200 prepgrade (GE Health-
care) in 20 mM phosphate buffer containing 0.15 M NaCl
(pH 7.4) for gel shift assays or 20 mM phosphate buffer containing
0.15 M NaCl (pH 6.8) for NMR. Finally, the protein samples were
concentrated by VIVASPIN 20 (10 000 MWCO PES) at 4uC.
Preparation of heparin-derived oligosaccharides
Sixty-two mg of low-weight porcine heparin was fractionated by
filtration on Bio-Gel P-6 (Bio-Rad laboratories, Hercules, CA) in
NH4HCO3 as described [21]. For NMR, commercial heparin-
derived oligosaccharides (tetrasaccharides : dp4, decasaccharides:
dp10 and dp14) were used (DEXTRA, UK). NMR and HPLC
analysis of these latter oligosaccharides showed that they were
homogeneous in size and composition. 75% of heparin is IdoA,2S
- GlcNS,6S.
Gel mobility shift assay
HBHA and oligosaccharides were mixed in 40 mL of binding
buffer (10 mM Tris-HCl, pH 7.5, 200 mM NaCl, 50 mM KCl,
1 mM EDTA and 0.5 mM DTT) for 30 min at 20uC [21]. The
samples were then supplemented with 10 mL of 60% glycerol and
subjected to electrophoresis in a 10% (w/v) native polyacrylamide
gel in 10 mM Tris, 1 mM EDTA (pH 7.4). Electrophoresis was
carried out at 100 V for 30 min. Bromophenol Blue was used as
electrophoresis markers. At the end of the electrophoresis,
oligosaccharides were stained by Azur blue. The gel was de-stained
in water and stained by Coomassie blue to visualize the proteins.
Peptide synthesis
Amino acid (AA) derivatives were obtained from GLS (Shanghai,
China). Coupling reagents were purchased from Merck Novabio-
chem (Darmstadt, Germany), Tentagel RAM resin from Rapp
Polymere (Tu ¨bingen, Germany). N-(9-Fluorenylmethoxycarbonyl)-
L-alanine-
15N and all other chemicals were purchased from Sigma-
Aldrich (Steinheim, Germany). Analytical RP-HPLC was per-
formed on a Varian ProStar 210 HPLC system and on a Shimadzu
10A HPLC system, equipped with a Nucleosil C18 column (5 mm,
4,66250 mm, Machery-Nagel), employing 0.1% TFA in water (A)
and 80% ACN, 0.1% TFA in water (B), as eluents. The analytical
gradient was 5–95% B over 50 min with a flow rate of 1 ml/min.
Preparative purifications were performed on a Varian ProStar 210
HPLC system equipped with a preparative Dynamax C18 column
(10 mm, 21,46250 mm, Varian) and a flow rate of 13 mL/min.
The peptides were analyzed by MALDI-MS on a MALDI-TOF-
TOF, 4700 Proteomics Analyzer (Applied Biosystems) and by
analytical RP-HPLC.
The peptide was synthesized using standard Fmoc-based solid-
phase chemistry on an Intavis Respep XL synthesizer in a 25 mmol
scale. TentaGel R RAM resin (loading 0.19 mmol/g) served as
solid support and amino acid side-chains were protected as follows:
Lys(Boc), Gln(Trt) and Thr(tBu). Coupling reactions were
achieved by using 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethylur-
onium-hexafluorophosphate (HBTU) as the activation agent and
N-Methylmorpholine (NMM) in DMF/NMP as base. Each
successive amino acid was doubly coupled in 5-fold molar excess.
Removal of the Fmoc group was carried out with 20% piperidine
in DMF.
The
15N-labeled alanine residues were introduced manually in a
single coupling reaction using 2-(7-aza-1H-benzotriazole-1-yl)-
1,1,3,3-tetramethyluronium hexafluorophosphate (HATU) and
NMM in DMF. These reactions were performed in 4 molar
excess for 1 h with a mixture of labeled Fmoc-amino acid
(100 mmol), HATU (90 mmol) and NMM (0.6 mmol) in DMF
followed by a capping step using Ac2O and N,N-Diisopropylethy-
lamine (DIPEA) in DMF. The peptide was cleaved off the resin
with complete removal of the side-chain protection groups with a
cleavage cocktail that contained TFA/Phenol/Triisopropylsilane/
H2O (85:5:5:5) for four hours. The cleaved product was
precipitated in cold diethyl ether, centrifuged and washed with
diethyl ether, dissolved in H2O and lyophilized. The crude peptide
was purified with preparative RP-HPLC.
NMR spectroscopy
NMR samples were prepared in 20 mM phosphate buffer
(pH 6.8), 0.15 M NaCl, 1 mM perdeuterated trimethyl silyl
propionate (TMSP-d4) as a reference and 5% D2O. NMR spectra
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PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e32421were recorded at 4uC and 20uC on a Bruker 600 Avance II or
Bruker 900 Avance III spectrometer, both equipped with a
cryogenically cooled probehead. HSQC spectra were recorded
with the standard Bruker sequence for the sensitivity enhanced
HSQC with gradient based water suppression, with 16 scans per
increment and 4 k6256 points in the t2, t1 directions. Fourier
transformation was done after zero filling and multiplication with
a p/4 and p/3 shifted square sine bell function for the t2 and
t1 directions, respectively. For the assignment, we recorded
HNCACB [39] and HN(CA)NNH [40] spectra at 4uC and
900 MHz on a 100 mM
15N,
13C labeled MalE-Ct sample, with or
without a 5.6-fold excess of dp14 (degree of polymerization), with
standard Bruker sequences. Acquisition parameters for the
HNCACB experiment were, for
1H (t3), 3 k points for 14 ppm,
for
15N (t2) 106 points for 24 ppm, and for
13C (t1), 256 points for
70 ppm. For the HNN experiment, the t1 dimension is
15N, and
256 points were acquired for 24 ppm. Spectra were processed
using Bruker TOPSPIN 2.1 software, after zero-filling to
4k 65126512 points and multiplication with a squared sine bell
window function.
Determination of dissociation constants using NMR
titration assays
For the titration experiments, 60 mM free
15N-labeled MalE-Ct
was added to appropriate amounts of lyophilized dp14 to obtain
dp14: MalE-Ct molecular ratios of 0.5, 1, 2, 5, and 10.
1H-
15N
HSQC spectra were acquired at 900 MHz and 20uC. The same
methodology was followed with the
15N-labeled samples of M.
tuberculosis and M. avium HBHA, but the spectra were acquired at
600 MHz.
Data analysis
The binding constant was calculated by fitting the formula
Dd~
Ddmax| dp ½ 
Kdz dp ½ 
to the observed resonances, with Dd as the
combined
1HNand
15Nch em ic alsh if tDd~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DdH ðÞ
2z0,2 DdN ðÞ
2
   r
Supporting Information
Table S1 Chemical shift predictions of the HBD, according to
the random coil chemical shifts defined from a set of intrinsically
unstructured proteins [42].
(DOC)
Figure S1 (A) The HNN plane extracted at the
15N frequency of
the (K)A(P) resonance (127.04 ppm; green) defines the
15N
frequency of the K(AP) resonance. Similarly, the plane extracted
at the latter frequency (123.03 ppm; blue) connects with the
(K)A(P) resonance, and defines the
1H frequency of the K(AP)
residue (8.368 ppm). (B) The HNN plane extracted at the
15N
frequency of the intense (K)A(AP) resonance (126.5 ppm; green)
defines the
15N frequency of the two (KA)A(P) resonance.
Similarly, the plane extracted at the third (K)A(AP) frequency
(126.15 ppm; blue) connects with its (KA)A(P) resonance. The
experiment equally connects the upstream K residues, degenerate
for repeats 1 and 2 (at 123.9 ppm) and at 123.6 ppm for repeat 3.
(PDF)
Figure S2 (A)
1H,
15N HSQC spectra of the MalE-Ct (black) of
the synthetic peptide at natural abundance (light blue) and of the
synthetic peptide incorporating a single
15N-Ala per repeat (dark
blue). Individual
15N-ala residues are indicated in blue on the
primary sequence. (B and C) Selected panels of the
1H,
15N
HSQC spectra of the MalE-Ct with an excess of dp14 (red) and of
the synthetic peptide incorporating a single
15N-Ala per repeat
with the same excess of dp14 (dark blue). (B) The (KK)A(AP) in the
third repeat is
15N labeled, and defines together with the HNN this
repeat. (C) Similarly, the (P)A resonance of the 2
nd repeat is
uniquely labeled, and defines the second repeat in the MalE-Ct.
(PDF)
Figure S3 Representative
15N HSQC NMR spectra for Ala-26 of
the MalE-Ct HBD domain (60 mM) (A, B and C) with increasing
amounts of derived oligosaccadrides shifting peaks used for the
determination of the dissociation constant: dp10 (A), dp14 (B) at the
following concentrations, free protein (black), 30 mM (red), 60 mM
(blue), 120 mM(purple), 300 mM (green) and 600 mM (marrow). (C)
free protein (black), equimolar ratio between MalE-Ct and dp4
(red), equimolar ration between MalE-Ct and dp10 (blue) and
equimolar ratio between MalE-Ct and dp14 (green). Chemical shift
differences were calculated as Dd
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DdH ðÞ
2z0,2 DdN ðÞ
2
   r
, where
DdH and DdN are the observed chemical shift changes for
1Ha n d
15N, respectively. For the determination of the dissociation
constants (D), Dd was plotted as a function of the molar ratio
(dp:protein) (E) Ala-6 (&) and Thr-37 (.) from the MalE-Ct HBD
domain bound to dp14; (F) Ala-26 from the MalE-Ct HBD bound
to dp14 (N) and dp10 (m).
(PDF)
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